Neurobo Pharmaceuticals Inc (NRBO) stock is lower by -72.60% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives NRBO stock a score of 34 out of a possible 100.
That rank is mainly influenced by a long-term technical score of 1. NRBO's rank also includes a short-term technical score of 10. The fundamental score for NRBO is 92. In addition to the average rating from Wall Street analysts, NRBO stock has a mean target price of 16. This means analysts expect the stock to climb 284.62% over the next 12 months.
What's Happening with NRBO Stock Today
Neurobo Pharmaceuticals Inc (NRBO) stock is down -5.45% while the S&P 500 is higher by 0.5% as of 12:16 PM on Thursday, Mar 4. NRBO is lower by -$0.24 from the previous closing price of $4.40 on volume of 177,423 shares. Over the past year the S&P 500 has gained 22.64% while NRBO is lower by -72.60%. NRBO lost -$2.77 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on Neurobo Pharmaceuticals Inc (NRBO) Stock.
